Cita APA

Cui, H., Wang, Q., Miller, D. D., & Li, W. (2021). The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma. Front Pharmacol.

Chicago Style Citation

Cui, Hongmei, Qinghui Wang, Duane D. Miller, i Wei Li. "The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma." Front Pharmacol 2021.

Cita MLA

Cui, Hongmei, Qinghui Wang, Duane D. Miller, i Wei Li. "The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma." Front Pharmacol 2021.